Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down to $338.55

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B) gapped down before the market opened on Wednesday . The stock had previously closed at $338.55, but opened at $281.55. Bio-Rad Laboratories shares last traded at $279.91, with a volume of 400 shares.

Bio-Rad Laboratories Price Performance

The firm has a 50 day moving average of $328.95 and a two-hundred day moving average of $318.44. The stock has a market capitalization of $7.98 billion, a PE ratio of -13.03 and a beta of 0.66. The company has a current ratio of 5.83, a quick ratio of 4.34 and a debt-to-equity ratio of 0.14.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings data on Thursday, February 15th. The company reported $3.10 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%. The firm had revenue of $681.18 million for the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.